Karyopharm Therapeutics Inc. · NASDAQ:KPTI
Adage Capital Management, L.P. reported a 8.08% stake in Karyopharm Therapeutics Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed May 13, 2026
Adage Capital Management, L.P. reported a 8.08% stake in Karyopharm Therapeutics Inc., 1,821,736 shares, as a passive investor on Mar 31, 2026. Filed May 13, 2026 (Schedule 13G).
- Stake
- 8.08%
- Shares
- 1,821,736
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Adage Capital Management, L.P. | 8.08% | 1,821,736 |
| Robert Atchinson | 8.08% | 1,821,736 |
| Phillip Gross | 8.08% | 1,821,736 |
Source
Related
- Karyopharm Therapeutics Inc.
- Adage Capital Management, L.P.
- Karyopharm Therapeutics Inc. shareholders
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · Feb 12, 2026
- Form 4 · Abate Kristin · Oct 19, 2026
- Schedule 13G/A · Anders Hove · Oct 8, 2026
- Form 4 · Abate Kristin · Oct 2, 2026
- Schedule 13G/A · Anders Hove · Sep 25, 2026
- Schedule 13G/A · Anders Hove · Sep 25, 2026